Influence of PDZK1 on lipoprotein metabolism and atherosclerosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 5, 2008, Pages 310-316

  Kocher, Olivier ^a   Yesilaltay, Ayce ^b   Shen, Ching Hung ^b   Zhang, Songwen ^b   Daniels, Kathleen ^a   Pal, Rinku ^a   Chen, Jianzhu ^b   Krieger, Monty ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Atherosclerosis; Cholesterol; HDL; PDZ domains; PDZK1; SR BI

Indexed keywords

ADAPTOR PROTEIN; APOLIPOPROTEIN E; CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; PDZK1 PROTEIN; PROTEIN DERIVATIVE; SCAVENGER RECEPTOR BI;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL DIET; CONTROLLED STUDY; GENE INACTIVATION; KNOCKOUT MOUSE; LIPID DIET; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD36; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIET; ENDOTHELIAL CELLS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPIDS; LIPOPROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL;

MURINAE; MUS;

EID: 42749084474     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.02.004     Document Type: Article

References (51)

1. Garcia C.K., Wilund K., Arca M., Zuliani G., Fellin R., Maioli M., Calandra S., Bertolini S., Cossu F., Grishin N., Barnes R., Cohen J.C., and Hobbs H.H. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292 (2001) 1394-1398
2. He G., Gupta S., Yi M., Michaely P., Hobbs H.H., and Cohen J.C. ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin and AP-2. J. Biol. Chem. 277 (2002) 44044-44049
3. V. Kumar, A. Abbas, N. Fuasto, Robbin's and Cotran pathologic basis of disease, Elsevier and Saunders 2005.
4. Soutar A., and Naoumova R. Mechanism of disease: genetic causes of familial hypercholesterolemia. Nat. Clin. Pract. Cardiovasc. Med. 4 (2007) 214-215
5. Zuliani G., Arca M., Signore A., Bader G., Fazio S., Chianelli M., Bellosta S., Campagna F., Montali A., Maioli M., Pacifico A., Ricci G., and Fellin R. Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 802-809
6. Reardon C., and Getz G. Mouse models of atherosclerosis. Curr. Opin. Lipidol. 12 (2001) 167-173
7. Glomset J. The plasma lecithins: cholesterol acyltransferase reaction. J. Lipid Res. 9 (1968) 155-167
8. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., and Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 (1996) 518-520
9. Mardones P., Quinones V., Amigo L., Moreno M., Miquel J.F., Schwarz M., Miettinen H., Trigatti B., Krieger M., VanPatten S., Cohen D.E., and Rigotti A. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J. Lipid Res. 42 (2001) 170-180
10. Trigatti B., Rayburn H., Vinals M., Braun A., Miettinen H., Penman M., Hertz M., Schrenzel M., Amigo L., Rigotti A., and Krieger M. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9322-9327
11. Rigotti A., Miettinen H., and Krieger M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr. rev. 24 (2003) 357-387
12. Kocher O., Yesilaltay A., Cirovic C., Pal R., Rigotti A., and Krieger M. Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J. Biol. Chem. 278 (2003) 52820-52825
13. Ikemoto M., Arai H., Feng D., Tanaka K., Aoki J., Dohmae N., Takio K., Adachi H., Tsujimoto M., and Inoue K. Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6538-6543
14. Silver D.L. A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver. J. Biol. Chem. 277 (2002) 34042-34047
15. Kocher O., Comella N., Tognazzi K., and Brown L.F. Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains. Lab. Invest. 78 (1998) 117-125
16. Webb N.R., Connell P.M., Graf G.A., Smart E.J., De Villiers W.J.S., De Beer F.C., and Van der Westhuyzen D.R. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J. Biol. Chem. 273 (1998) 15241-15248
17. Webb N.R., De Villiers W.J.S., Connell P.M., De Beer F.C., and Van der Westhuyzen D.R. Alternative forms of the scavenger receptor BI (SR-BI). J. Lipid Res. 38 (1997) 1490-1495
18. Braun A., Zhang S., Miettinen H., Ebrahim S., Holm T., Vasile E., Post M.J., Yoerger D., Picard M., Krieger J., Andrews N., Simons M., and Krieger M. Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7283-7288
19. Rigotti A., Trigatti B.L., Penman M., Rayburn H., Herz J., and Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12610-12615
20. Yesilaltay A., Kocher O., Pal R., Leiva A., Quinones V., Rigotti A., and Krieger M. PDZK1 is required for maintaining hepatic scavenger receptor, class B, type I (SR-BI) steady state levels but not its surface localization or function. J. Biol. Chem. 281 (2006) 28975-28980
21. Braun A., Trigatti B.L., Post M.J., Sato K., Simons M., Edelberg J.M., Rosenberg R.D., Schrenzel M., and Krieger M. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ. Res. 90 (2002) 270-276
22. Van Eck M., Twisk J., Hoekstra M., Van Rij B., Van der Lans C., Bos I., Kruijt J., Kuipers F., and Van Berkel T. Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J. Biol. Chem. 278 (2003) 23699-23705
23. Arai T., Wang N., Bezouevski M., Welch C., and Tall A. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scaveger receptor BI transgene. J. Biol. Chem. 274 (1999) 2266-2271
24. Kozarsky K., Donahee M., Glick J., Krieger M., and Rader D. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 721-727
25. Krieger M., and Kozarsky K. Influence of the HDL receptor SR-BI on atherosclerosis. Curr. Opin. Lipidol. 10 (1999) 491-497
26. Trigatti B., Krieger M., and Rigotti A. Influence of HDL receptor ST-BI on lipoprotein metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1732-1738
27. Zhang W., Yancey P.G., Su Y.R., Babaev V.R., Zhang Y., Fazio S., and Linton M.F. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108 (2003) 2258-2263
28. Kocher O., Pal R., Roberts M., Cirovic C., and Gilchrist A. Targeted disruption of the PDZK1 gene by homologous recombination. Mol. Cell. Biol. 23 (2003) 1175-1180
29. Yesilaltay A., Morales M., Amigo L., Zanlungo S., Rigotti A., Karackattu S., Donahee M., Kozarsky K., and Krieger M. Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female infertility. Endocrinology 147 (2006) 1577-1588
30. Saxena U., and Goldberg I.J. Endothelial cells and atherosclerosis: lipoprotein metabolsim, matrix interactions and monocyte recruitment. Curr. Opin. Lipidol. 5 (1994) 316-322
31. Gu X., Kozarsky K., and Krieger M. Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J. Biol. Chem. 275 (2000) 29993-30001
32. Buechler C., Ritter M., Quoc C.D., Agildere A., and Schmitz G. Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages. Biochem. Biophys. Res. Commun. 262 (1999) 251-254
33. Norata G.D., Ongari M., Uboldi P., Pellegatta F., and Catapano A.L. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells. Int. J. Mol. Med. 16 (2005) 717-722
34. Plump A., Smith J., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J., Rubin E., and Breslow J. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71 (1992) 343-353
35. Zhang S., Reddick R., Burkey B., and Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J. Clin. Invest. 94 (1994) 937-945
36. Ma K., Forte T., Otvos J., and Chan L. Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse models. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 149-154
37. Voshol P., Schwarz M., Rigotti A., Krieger M., Groen A., and Kuipers F. Down-regulation of intestinal scavenger receptor class B type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine. Biochem. J. 356 (2001) 317-325
38. Kimura T., Tomura H., Mogi C., Kuwabara A., Damirin A., Ishizuka T., Sekiguchi A., Ishiwara M., Im D., Sato K., Murakami M., and Okajima F. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J. Biol. Chem. 281 (2006) 37457-37467
39. Assanasen C., Mineo C., Seetharam D., Yuhanna I.S., Marcel Y.L., Connelly M.A., Williams D.L., de la Llera-Moya M., Shaul P.W., and Silver D.L. Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J. Clin. Invest. 115 (2005) 969-977
40. Plump A., Erickson S., Weng W., Partin J., Breslow J., and Williams D.L. Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J. Clin. Invest. 97 (1996) 2660-2671
41. Necela B., and Cidlowski J. Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc. Am. Thorac. Soc. 1 (2004) 239-246
42. Cai L., Ji A., De Beer F.C., Tannock L.R., and Van der Westhuyzen D.R. SR-BI protects against endotoxemia in mice through its role in glucocorticoid production and hepatic clearance. J. Clin. Invest. 118 (2008) 364-375
43. Eckhardt E.R., Cai L., Shetty S., Zhao Z., Szanto A., Webb N.R., and Van der Westhuyzen D.R. High density lipoprotein endocytosis by scavenger receptor SR-BII is clathrin-dependent and requires a carboxyl-terminal dileucine motif. J. Biol. Chem. 281 (2006) 4348-4353
44. Bellosta S., Mahley R., Sanan D., Murata J., Newland D., Taylor J., and Pitas R. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96 (1995) 2170-2179
45. Boisvert W., Spangenberg J., and Curtiss L. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96 (1995) 1118-1124
46. Linton M.F., Atkinson J., and Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267 (1995) 1034-1037
47. Thorngate F., Rudel L., Walzem R., and Williams D.L. Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1939-1945
48. Van Eck M., Herijgers N., Yates J., Pearce N., Hoogerbrugge P., Groot P., and Van Berkel T. Bone marrow transplantation in apolipoprotein E-deficient mice: effect of apoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3117-3126
49. Yu H., Zhang W., Yancey P.G., Koury M.J., Zhang Y., Fazio S., and Linton M.F. Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor-class BI double-knockout mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 150-156
50. Zhang S., Picard M., Vasile E., Zhu Y., Raffai R., Weisgraber K., and Krieger M. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient hypomorphic apolipoprotein ER61 mice. Circulation 111 (2005) 3457-3464
51. Fellin R., Zuliani G., Arca M., Pintus P., Pacifico A., Montali A., Corsini A., and Maioli M. Clinical and biochemical characterization of patients with autosomal recessive hypercholesterolemia (ARH). Nutr. Metab. Cardiovasc. Dis. 13 (2003) 278-286